CD226 Antikörper (pSer329)
-
- Target Alle CD226 Antikörper anzeigen
- CD226
-
Bindungsspezifität
- pSer329
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CD226 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
- Kreuzreaktivität
- Human, Affe, Maus
- Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- Synthesized peptide derived from Human DNAM-1 around the phosphorylation site of S329.
- Isotyp
- IgG
- Top Product
- Discover our top product CD226 Primärantikörper
-
-
- Applikationshinweise
- WB:1:500-1:2000, IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:40000,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- CD226
- Andere Bezeichnung
- CD226 (CD226 Produkte)
- Synonyme
- CD226 antikoerper, cd226 antikoerper, zgc:158817 antikoerper, BC051526 antikoerper, DNAM-1 antikoerper, DNAM1 antikoerper, Pta1 antikoerper, TLiSA1 antikoerper, PTA1 antikoerper, CD226 molecule antikoerper, CD226 antigen antikoerper, CD226 antikoerper, cd226 antikoerper, Cd226 antikoerper
- Hintergrund
- Adhesion glycoprotein antibody, CD226 antibody, CD226 antigen antibody, CD226 Molecule antibody, CD226_HUMAN antibody, DNAM 1 antibody, DNAM-1 antibody, DNAM1 antibody, DNAX accessory molecule 1 antibody, platelet and T cell activation antigen 1 antibody, PTA1 antibody, T lineage specific activation antigen 1 antigen antibody, TLiSA1 antibody
- UniProt
- Q15762
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
-